Benzinga | Jan 7, 2022 01:07PM EST

Morgan Stanley Maintains Equal-Weight on NuVasive, Lowers Price Target to $60

Morgan Stanley maintains NuVasive (NASDAQ:NUVA) with a Equal-Weight and lowers the price target from $62 to $60.